Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Locations

Education & Training

  • MA, Educational Technology Leadership, 2008
    George Washington University
  • Fellowship Program, Pediatric Infectious Diseases, 1984
    Texas Children's Hospital-Baylor College of Med.
  • Residency Program, Pediatrics, 1982
    Texas Children's Hospital-Baylor College of Med.
  • Residency Program, Pediatrics, 1981
    Texas Children's Hospital-Baylor College of Med.
  • MD, 1978
    Baylor College of Medicine
  • BA, Biochemistry, 1975
    Rice University

Board Certifications

  • American Board of Pediatrics
  • American Board of Pediatrics/Infectious Diseases

Awards & Recognition

  • Top Doctors No Va Magazine (2018, 2017, 2016, 2015)
  • Top Doctors Washingtonian (2018, 2017, 2016, 2015)

National Provider ID: 1518911791


Biography

Bernhard Wiedermann, M.D., MA, is a specialist in pediatric infectious diseases. His research and clinical interests include: general pediatric infections such as Lyme disease, unexplained and recurrent fevers, malaria and other tropical diseases, bone and joint infections, medical education, distance learning and telemedicine and evidence-based medicine.

Dr. Wiedermann is author of an evidence-based medicine blog for the American Academy of Pediatrics called "Evidence eMended." He also serves on the data monitoring committee for research conducted via the National Institutes of Health Best Pharmaceuticals for Children Act and directs the pediatric infectious diseases fellowship program at Children’s National.

Dr. Wiedermann received his M.D. degree from Baylor College of Medicine and then completed a pediatric residency and chief residency at Texas Children’s Hospital, followed by a pediatric infectious diseases fellowship at the same institution. He also earned a master’s degree in Educational Technology Leadership from The George Washington University School of Education and Human Development.

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

Outside Interests

  • American Academy of Pediatrics, 
  • US Food and Drug Administration (FDA), 
  • Emmes Corporation




Emergence of multidrug-resistant influenza A (H1N1) pdm09 virus variants in an immunocompromised child treated with oseltamivir and zanamivir.
(2015) Journal of Infectious Disease

Management of hospitalized febrile neonates without CSF analysis: a study of US pediatric hospitals.
(2015) Hospital Pediatrics

Learning to deliver care in a medical home: a qualitative analysis of residents’ reflections on practice.
(2014) Clinical Pediatrics

What’s wrong with acellular pertussis vaccines? 
(2013) Clinical Therapeutics

Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines
(2012) Pediatric Cardiology